Pharmacyclics Inc (NASDAQ:PCYC)

Friday’s trading has closed, but PCYC is being traded in the after-hours session. After-Hours quote »
254.56
Delayed Data
As of 4:00pm ET
 +0.34 / +0.13%
Today’s Change
82.51
Today|||52-Week Range
255.52
+108.21%
Year-to-Date
Pharmacyclics Set to Be Acquired by AbbVie for $21B - Analyst Blog
6:04pm / Zacks.com
Did AbbVie Just Grossly Overpay for Pharmacyclics Inc.?
Mar 05 / MotleyFool.com
Going the extra mile to win a B#21bn deal
2:28pm / FT.com
Frontrunning: March 5
Mar 05 / Investing Channel
Stock Market News for March 06, 2015 - Market News
10:55am / Zacks.com
Abbvie/Pharmacyclics: pay to play
Mar 05 / FT.com
Frontrunning: March 6
8:33am / Investing Channel
US Stock Futures Up Ahead Of Jobless Claims, Factory Orders Data
Mar 05 / Benzinga
Benzinga's M&A Chatter for Thursday March 5, 2015
Mar 05 / Benzinga
Trade-Ideas: Pharmacyclics (PCYC) Is Today's Pre-Market Mover With Heavy Volume Stock
Mar 05 / TheStreet.com
That's Just What's Supposed to Happen
Mar 05 / TheStreet.com
Why Pharmacyclics Inc. Stock Burst Higher
Mar 05 / MotleyFool.com
The Under-the-Radar Reason Why Puma Biotechnology Inc. Rocketed 17% Higher
Mar 05 / MotleyFool.com
AbbVie Spending Historic Amount of Cash to Buy Half of a Cancer Drug
Mar 05 / TheStreet.com
AbbVie wins three-way fight over Pharmacyclics
Mar 05 / FT.com
Q&A - why Abbvie had to strike $21bn Pharmacyclics deal
Mar 05 / FT.com
AbbVie joins the pharma chain reaction
Mar 05 / FT.com
China Cuts Growth Target
Mar 05 / TheStreet.com
Vertex climbs on drug approval hopes
Mar 05 / FT.com
Stocks: 5 things to know before the open
Mar 05 / CNNMoney.com
Pharmacyclics CEO sees stake value soar
Mar 05 / FT.com
China's rubber stamp parliament, AbbVie's acquisition of Pharmacyclics and the origin...
Mar 05 / FT.com
Centerview builds record on pharma deals
Mar 05 / FT.com
Benzinga's M&A Chatter for Wednesday March 4, 2015
Mar 04 / Benzinga
Benzinga's Volume Movers
Mar 05 / Benzinga
Report: Pharmacyclics Inc. To Be Acquired By Johnson & Johnson
Mar 04 / Benzinga
Stocks Hitting 52-Week Highs
Mar 05 / Benzinga
AbbVie trumps J&J in deal for cancer drugmaker
Mar 04 / FT.com
Morning Market Losers
Mar 05 / Benzinga
Trade-Ideas: Pharmacyclics (PCYC) Is Today's Strong On High Relative Volume Stock
Mar 04 / TheStreet.com
Notable Mergers and Acquisitions 3/5: (ABBV)/(PCYC) (MNK) (SMTC)
Mar 05 / Investing Channel
3 Biotech Stocks That Are Soaring Higher
Mar 03 / MotleyFool.com
How These Healthcare Megadeals Helped Send the Market Higher
Mar 05 / MotleyFool.com
3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year
Mar 01 / MotleyFool.com
Pharmacyclics (PCYC) Stock Spikes Today Following $21 Billion AbbVie Merger Deal
Mar 05 / TheStreet.com
Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded...
Feb 26 / Zacks.com
Company News for March 05, 2015 - Corporate Summary
Mar 05 / Zacks.com
Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors - Analyst Blog
Feb 26 / Zacks.com
Morning Market Gainers
Mar 05 / Benzinga
Pharmacyclics considers $19bn sale
Feb 25 / FT.com
AbbVie to Acquire Pharmacyclics: What Wall Street's Saying
Mar 05 / TheStreet.com
Why Pharmacyclics, Inc. Soared Higher Today
Feb 25 / MotleyFool.com
On the ECB & China's Growth - Ahead of Wall Street
Mar 05 / Zacks.com
Can the Rally in Pharmacyclics (PCYC) Shares Continue? - Tale of the Tape
Feb 25 / Zacks.com
Benzinga's Top #PreMarket Losers
Mar 05 / Benzinga
There Are Crazy Valuations, and Then There Are the Valuations of These 3 Stocks
Feb 22 / MotleyFool.com
Benzinga's Top #PreMarket Gainers
Mar 05 / Benzinga
 

To view my watchlist

Not a member yet?

Sign up now for a free account